What's Behind the USPSTF's Aspirin Guidance
The US Preventive Services Task Force (USPSTF) just released new guidance on daily aspirin to prevent cardiovascular disease (CVD) and colorectal cancer. But what was behind that recommendation?
Good Health Before Cancer: A Survival Booster
A healthy lifestyle — marked by healthy eating, exercise and a healthy weight — can help prevent cancer. In patients who get cancer, that same lifestyle may help them live longer.
Colorectal Cancer: A Family Matter
For most people, colonoscopy screening for colorectal cancer should begin at age 50. If everything looks good, the next colonoscopy happens 10 years later. For folks with a family history of the disease, earlier and more frequent screenings are recommended. But even that may not be enough.
Primary Care Doctor Visits Save Lives
Research has shown that screening cuts the incidence of colorectal cancer. And folks who visit their doctors regularly are more likely to learn about and be referred for colorectal cancer screening. Do these two facts save lives?
FDA Approves First Generic Capecitabine to Treat Colorectal and Breast Cancers
The US Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic), and metastatic breast cancer.
Accepting Cancer Screening Invitations
Even though colorectal cancer is one of the most common cancers in the US, getting screened for the disease isn’t all that popular. This is especially true for people without insurance. In an effort to improve screening rates, some one-on-one attention did the trick.
Unraveling Family Cancer Ties
Having a family history of any kind of cancer isn’t a bright spot for your own odds. It’s just part of nature over which we have no control. In terms of colorectal cancer, new understandings may help avoid a nightmare journey.
Realistic Expectations Are a Good Thing
Hope is an important part of fighting cancer. But unrealistic optimism in the final stages of cancer can influence important patient decisions.